Aside from the recent requirement to move toward annual accreditation, the default rule presumes legacy DME suppliers remain compliant until their current Medicare credentialing period expires … even if that expiration is more than a year away. Medicare will require annual accreditation renewals thereafter. So, yes, suppliers recredentialed in the last year or two may not have to think about accreditation this year, but … We suspect the return of competitive bidding may fuel a rise in business mergers, reorganizations, and changes in ownership. Those transactions could accelerate reaccreditation time tables, and in some circumstances, require a new PTAN altogether.

All Tax ID Changes Require New PTANs

Anytime a DME supplier changes its tax identification number, Medicare requires the entity to obtain a new PTAN. A new PTAN requires a site survey, accreditation, and all the other elements of a new enrollment application. Suppliers should assume any transaction necessitating a tax ID change will accelerate the deadline to renew accreditation. It is important to engage accrediting organizations (AOs) as soon as possible. If the AO will not transfer the current accreditation, or does not complete the renewal process before the transaction date, the supplier will be out of compliance and at risk for losing Medicare billing privileges.

Changes in Majority Ownership

Medicare requires a new PTAN when there is a change of ownership affecting 50 percent or more of the interests and the supplier has:
  1. Operated for less than three years, or
  2. Completed a change in majority ownership (>= 50 percent) in the previous three years.
CMS does make select exceptions to these three-year window restrictions. New PTANs are not required if:
  1. The supplier’s parent company undergoes an internal corporate restructure through a merger or consolidation.
  2. The business structure changes, but the owners remain the same.
  3. One owner passes away, forcing a replacement or change in ownership.
Otherwise, these new PTAN requirements may accelerate the enrollment responsibilities and reaccreditation deadlines, much like a change in tax ID. Much like we discussed in last week’s (K)newsletter, reaccreditation must be a condition – not an afterthought – when contemplating transactions that could change the majority ownership or require a new tax identification number.

Implications of the Moratorium on DME Enrollment (CMS-6099-N)

On February 25, 2026, CMS announced a nationwide moratorium on the enrollment of new DME supplier locations. While CMS stated the purpose of the moratorium is to combat rampant fraud, waste, and abuse, the move is consistent with its explicit goal of shrinking the number of participating DME suppliers. Suppliers engaging in actions requiring new PTANs may not be able to get them during the moratorium. Those risks must be considered in advance of action. MiraVista maintains DME suppliers need to know the rules in place before contemplating the temporary moratorium, and we are preparing educational content like this (K)newsletter accordingly.